NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

The only reason for a R/S is if the company were to up list, which they have not announced any intention or made application to do so. In any event, NWBO would also have to reach a final settlement with SEC before Nasdaq would even consider an application from these saints that they've had prior experience with.

I am starting to think LP will try to time a R/S with topline release. I hope not, but does anyone else think that this could be? Watching how she operates, a 1-10 reverse split and subsequent uplisting, timed with positive topline might prevent additional shorting due to positive data? And then, that insures PPS for warrant conversion and additional operating cash to get to FDA approval....